http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 09 Jul 2026 09:59:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Scinai+Immunotherapeutic+++++++++++++++Filed+by%3A+LCK+JNK+1+LLC/26751394.html si-local-file:///var/storage/secattach/20260709/26751394.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Scinai+Immunotherapeutic+++++++++++++++Filed+by%3A+LCK+JNK+1+LLC/26751394.html Thu, 09 Jul 2026 09:59:00 -0400 2F5 O.05713057 SCNI http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Scinai+Immunotherapeutic+++++++++++++++Filed+by%3A+LCK+JNK+1+LLC/26751394.html si-local-file:///var/storage/secattach/20260709/26751394.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Scinai+Immunotherapeutic+++++++++++++++Filed+by%3A+LCK+JNK+1+LLC/26751394.html Thu, 09 Jul 2026 09:59:00 -0400 2F5 O.05713057 SCNI http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Scinai+Immunotherapeutic+++++++++++++++Filed+by%3A+LCK+JNK+1+LLC/26751394.html si-local-file:///var/storage/secattach/20260709/26751394.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Scinai+Immunotherapeutic+++++++++++++++Filed+by%3A+LCK+JNK+1+LLC/26751394.html Thu, 09 Jul 2026 09:59:00 -0400 2F5 O.05713057 SCNI http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Scinai+Immunotherapeutic+++++++++++++++Filed+by%3A+STONE+DANIEL+E./26722220.html si-local-file:///var/storage/secattach/20260701/26722220.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Scinai+Immunotherapeutic+++++++++++++++Filed+by%3A+STONE+DANIEL+E./26722220.html Wed, 01 Jul 2026 17:29:00 -0400 2F5 O.05713057 SCNI http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Scinai+Immunotherapeutic+++++++++++++++Filed+by%3A+STONE+DANIEL+E./26722220.html si-local-file:///var/storage/secattach/20260701/26722220.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Scinai+Immunotherapeutic+++++++++++++++Filed+by%3A+STONE+DANIEL+E./26722220.html Wed, 01 Jul 2026 17:29:00 -0400 2F5 O.05713057 SCNI http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Scinai+Immunotherapeutic+++++++++++++++Filed+by%3A+STONE+DANIEL+E./26722220.html si-local-file:///var/storage/secattach/20260701/26722220.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Scinai+Immunotherapeutic+++++++++++++++Filed+by%3A+STONE+DANIEL+E./26722220.html Wed, 01 Jul 2026 17:29:00 -0400 2F5 O.05713057 SCNI http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Scinai+Immunotherapeutic++For%3A+Jun+16++Filed+by%3A+GERMAIN+MARK/26665468.html si-local-file:///var/storage/secattach/20260618/26665468.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Scinai+Immunotherapeutic++For%3A+Jun+16++Filed+by%3A+GERMAIN+MARK/26665468.html Thu, 18 Jun 2026 14:51:00 -0400 2F5 O.05713057 SCNI http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Scinai+Immunotherapeutic++For%3A+Jun+16++Filed+by%3A+GERMAIN+MARK/26665468.html si-local-file:///var/storage/secattach/20260618/26665468.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Scinai+Immunotherapeutic++For%3A+Jun+16++Filed+by%3A+GERMAIN+MARK/26665468.html Thu, 18 Jun 2026 14:51:00 -0400 2F5 O.05713057 SCNI http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Scinai+Immunotherapeutic++For%3A+Jun+16++Filed+by%3A+GERMAIN+MARK/26665468.html si-local-file:///var/storage/secattach/20260618/26665468.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Scinai+Immunotherapeutic++For%3A+Jun+16++Filed+by%3A+GERMAIN+MARK/26665468.html Thu, 18 Jun 2026 14:51:00 -0400 2F5 O.05713057 SCNI http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Scinai+Immunotherapeutic++For%3A+Jun+16++Filed+by%3A+Reichman+Amir/26665455.html si-local-file:///var/storage/secattach/20260618/26665455.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Scinai+Immunotherapeutic++For%3A+Jun+16++Filed+by%3A+Reichman+Amir/26665455.html Thu, 18 Jun 2026 14:49:00 -0400 2F5 O.05713057 SCNI http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Scinai+Immunotherapeutic++For%3A+Jun+16++Filed+by%3A+Reichman+Amir/26665455.html si-local-file:///var/storage/secattach/20260618/26665455.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Scinai+Immunotherapeutic++For%3A+Jun+16++Filed+by%3A+Reichman+Amir/26665455.html Thu, 18 Jun 2026 14:49:00 -0400 2F5 O.05713057 SCNI http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Scinai+Immunotherapeutic++For%3A+Jun+16++Filed+by%3A+Reichman+Amir/26665455.html si-local-file:///var/storage/secattach/20260618/26665455.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Scinai+Immunotherapeutic++For%3A+Jun+16++Filed+by%3A+Reichman+Amir/26665455.html Thu, 18 Jun 2026 14:49:00 -0400 2F5 O.05713057 SCNI http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Scinai+Immunotherapeutic++For%3A+Jun+17/26656411.html si-local-file:///var/storage/secattach/20260617/26656411.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Scinai+Immunotherapeutic++For%3A+Jun+17/26656411.html Wed, 17 Jun 2026 06:03:00 -0400 2F5 O.05713057 SCNI http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Scinai+Immunotherapeutic++For%3A+Jun+17/26656411.html si-local-file:///var/storage/secattach/20260617/26656411.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Scinai+Immunotherapeutic++For%3A+Jun+17/26656411.html Wed, 17 Jun 2026 06:03:00 -0400 2F5 O.05713057 SCNI http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Scinai+Immunotherapeutic++For%3A+Jun+17/26656411.html si-local-file:///var/storage/secattach/20260617/26656411.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Scinai+Immunotherapeutic++For%3A+Jun+17/26656411.html Wed, 17 Jun 2026 06:03:00 -0400 2F5 O.05713057 SCNI http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Scinai+Immunotherapeutic++For%3A+Jun+15/26643977.html si-local-file:///var/storage/secattach/20260615/26643977.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Scinai+Immunotherapeutic++For%3A+Jun+15/26643977.html Mon, 15 Jun 2026 06:48:00 -0400 2F5 O.05713057 SCNI http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Scinai+Immunotherapeutic++For%3A+Jun+15/26643977.html si-local-file:///var/storage/secattach/20260615/26643977.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Scinai+Immunotherapeutic++For%3A+Jun+15/26643977.html Mon, 15 Jun 2026 06:48:00 -0400 2F5 O.05713057 SCNI http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Scinai+Immunotherapeutic++For%3A+Jun+15/26643977.html si-local-file:///var/storage/secattach/20260615/26643977.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Scinai+Immunotherapeutic++For%3A+Jun+15/26643977.html Mon, 15 Jun 2026 06:48:00 -0400 2F5 O.05713057 SCNI http://www.streetinsider.com/Press+Releases/Scinai+Reports+First+Quarter+2026+Financial+Results+and+Provides+Corporate+Update+Highlighting+Expansion+of+CDMO+Platform+and+Advancement+of+Strategic+Growth+Initiatives/26626830.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/il..jerusl" idsrc="xmltag.org" >JERUSALEM</location></span>, <span class="legendSpanClass"><chron>June 10, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.scinai.com/cdmo" target="_blank" rel="nofollow"><span value="Frankfurt:2F5" idsrc="xmltag.org" >Scinai Immunotherapeutics Ltd</span></a>. (NASDAQ: SCNI), ("Scinai" or the "Company"), a biopharmaceutical company combining innovative therapeutic development with a revenue-generating CDMO subsidiary, today reported financial results for the three months ended <chron>March 31, 2026</chron> and provided a corporate update.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> <img src="https://mmx.prnewswire.com/media/MS1069511/Scinai_Immunotherapeutics_Logo.jpg?id=OA2695551" http://www.streetinsider.com/Press+Releases/Scinai+Reports+First+Quarter+2026+Financial+Results+and+Provides+Corporate+Update+Highlighting+Expansion+of+CDMO+Platform+and+Advancement+of+Strategic+Growth+Initiatives/26626830.html Wed, 10 Jun 2026 07:55:00 -0400 2F5 2F5.MU A.50113769 O.00624550 O.05713057 SCNI http://www.streetinsider.com/Press+Releases/Scinai+Reports+First+Quarter+2026+Financial+Results+and+Provides+Corporate+Update+Highlighting+Expansion+of+CDMO+Platform+and+Advancement+of+Strategic+Growth+Initiatives/26626830.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/il..jerusl" idsrc="xmltag.org" >JERUSALEM</location></span>, <span class="legendSpanClass"><chron>June 10, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.scinai.com/cdmo" target="_blank" rel="nofollow"><span value="Frankfurt:2F5" idsrc="xmltag.org" >Scinai Immunotherapeutics Ltd</span></a>. (NASDAQ: SCNI), ("Scinai" or the "Company"), a biopharmaceutical company combining innovative therapeutic development with a revenue-generating CDMO subsidiary, today reported financial results for the three months ended <chron>March 31, 2026</chron> and provided a corporate update.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> <img src="https://mmx.prnewswire.com/media/MS1069511/Scinai_Immunotherapeutics_Logo.jpg?id=OA2695551" http://www.streetinsider.com/Press+Releases/Scinai+Reports+First+Quarter+2026+Financial+Results+and+Provides+Corporate+Update+Highlighting+Expansion+of+CDMO+Platform+and+Advancement+of+Strategic+Growth+Initiatives/26626830.html Wed, 10 Jun 2026 07:55:00 -0400 2F5 2F5.MU A.50113769 O.00624550 O.05713057 SCNI http://www.streetinsider.com/Press+Releases/Scinai+Reports+First+Quarter+2026+Financial+Results+and+Provides+Corporate+Update+Highlighting+Expansion+of+CDMO+Platform+and+Advancement+of+Strategic+Growth+Initiatives/26626830.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/il..jerusl" idsrc="xmltag.org" >JERUSALEM</location></span>, <span class="legendSpanClass"><chron>June 10, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.scinai.com/cdmo" target="_blank" rel="nofollow"><span value="Frankfurt:2F5" idsrc="xmltag.org" >Scinai Immunotherapeutics Ltd</span></a>. (NASDAQ: SCNI), ("Scinai" or the "Company"), a biopharmaceutical company combining innovative therapeutic development with a revenue-generating CDMO subsidiary, today reported financial results for the three months ended <chron>March 31, 2026</chron> and provided a corporate update.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> <img src="https://mmx.prnewswire.com/media/MS1069511/Scinai_Immunotherapeutics_Logo.jpg?id=OA2695551" http://www.streetinsider.com/Press+Releases/Scinai+Reports+First+Quarter+2026+Financial+Results+and+Provides+Corporate+Update+Highlighting+Expansion+of+CDMO+Platform+and+Advancement+of+Strategic+Growth+Initiatives/26626830.html Wed, 10 Jun 2026 07:55:00 -0400 2F5 2F5.MU A.50113769 O.00624550 O.05713057 SCNI http://www.streetinsider.com/Press+Releases/Scinai+Reports+First+Quarter+2026+Financial+Results+and+Provides+Corporate+Update+Highlighting+Expansion+of+CDMO+Platform+and+Advancement+of+Strategic+Growth+Initiatives/26626830.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/il..jerusl" idsrc="xmltag.org" >JERUSALEM</location></span>, <span class="legendSpanClass"><chron>June 10, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.scinai.com/cdmo" target="_blank" rel="nofollow"><span value="Frankfurt:2F5" idsrc="xmltag.org" >Scinai Immunotherapeutics Ltd</span></a>. (NASDAQ: SCNI), ("Scinai" or the "Company"), a biopharmaceutical company combining innovative therapeutic development with a revenue-generating CDMO subsidiary, today reported financial results for the three months ended <chron>March 31, 2026</chron> and provided a corporate update.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> <img src="https://mmx.prnewswire.com/media/MS1069511/Scinai_Immunotherapeutics_Logo.jpg?id=OA2695551" http://www.streetinsider.com/Press+Releases/Scinai+Reports+First+Quarter+2026+Financial+Results+and+Provides+Corporate+Update+Highlighting+Expansion+of+CDMO+Platform+and+Advancement+of+Strategic+Growth+Initiatives/26626830.html Wed, 10 Jun 2026 07:55:00 -0400 2F5 2F5.MU A.50113769 O.00624550 O.05713057 SCNI http://www.streetinsider.com/Press+Releases/Scinai+Reports+First+Quarter+2026+Financial+Results+and+Provides+Corporate+Update+Highlighting+Expansion+of+CDMO+Platform+and+Advancement+of+Strategic+Growth+Initiatives/26626830.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/il..jerusl" idsrc="xmltag.org" >JERUSALEM</location></span>, <span class="legendSpanClass"><chron>June 10, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.scinai.com/cdmo" target="_blank" rel="nofollow"><span value="Frankfurt:2F5" idsrc="xmltag.org" >Scinai Immunotherapeutics Ltd</span></a>. (NASDAQ: SCNI), ("Scinai" or the "Company"), a biopharmaceutical company combining innovative therapeutic development with a revenue-generating CDMO subsidiary, today reported financial results for the three months ended <chron>March 31, 2026</chron> and provided a corporate update.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> <img src="https://mmx.prnewswire.com/media/MS1069511/Scinai_Immunotherapeutics_Logo.jpg?id=OA2695551" http://www.streetinsider.com/Press+Releases/Scinai+Reports+First+Quarter+2026+Financial+Results+and+Provides+Corporate+Update+Highlighting+Expansion+of+CDMO+Platform+and+Advancement+of+Strategic+Growth+Initiatives/26626830.html Wed, 10 Jun 2026 07:55:00 -0400 2F5 2F5.MU A.50113769 O.00624550 O.05713057 SCNI http://www.streetinsider.com/Press+Releases/Scinai+Reports+First+Quarter+2026+Financial+Results+and+Provides+Corporate+Update+Highlighting+Expansion+of+CDMO+Platform+and+Advancement+of+Strategic+Growth+Initiatives/26626830.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/il..jerusl" idsrc="xmltag.org" >JERUSALEM</location></span>, <span class="legendSpanClass"><chron>June 10, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.scinai.com/cdmo" target="_blank" rel="nofollow"><span value="Frankfurt:2F5" idsrc="xmltag.org" >Scinai Immunotherapeutics Ltd</span></a>. (NASDAQ: SCNI), ("Scinai" or the "Company"), a biopharmaceutical company combining innovative therapeutic development with a revenue-generating CDMO subsidiary, today reported financial results for the three months ended <chron>March 31, 2026</chron> and provided a corporate update.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> <img src="https://mmx.prnewswire.com/media/MS1069511/Scinai_Immunotherapeutics_Logo.jpg?id=OA2695551" http://www.streetinsider.com/Press+Releases/Scinai+Reports+First+Quarter+2026+Financial+Results+and+Provides+Corporate+Update+Highlighting+Expansion+of+CDMO+Platform+and+Advancement+of+Strategic+Growth+Initiatives/26626830.html Wed, 10 Jun 2026 07:55:00 -0400 2F5 2F5.MU A.50113769 O.00624550 O.05713057 SCNI http://www.streetinsider.com/PRNewswire/Scinai+Reports+First+Quarter+2026+Financial+Results+and+Provides+Corporate+Update+Highlighting+Expansion+of+CDMO+Platform+and+Advancement+of+Strategic+Growth+Initiatives/26626830.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/il..jerusl" idsrc="xmltag.org" >JERUSALEM</location></span>, <span class="legendSpanClass"><chron>June 10, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.scinai.com/cdmo" target="_blank" rel="nofollow"><span value="Frankfurt:2F5" idsrc="xmltag.org" >Scinai Immunotherapeutics Ltd</span></a>. (NASDAQ: SCNI), ("Scinai" or the "Company"), a biopharmaceutical company combining innovative therapeutic development with a revenue-generating CDMO subsidiary, today reported financial results for the three months ended <chron>March 31, 2026</chron> and provided a corporate update.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> <img src="https://mmx.prnewswire.com/media/MS1069511/Scinai_Immunotherapeutics_Logo.jpg?id=OA2695551" http://www.streetinsider.com/PRNewswire/Scinai+Reports+First+Quarter+2026+Financial+Results+and+Provides+Corporate+Update+Highlighting+Expansion+of+CDMO+Platform+and+Advancement+of+Strategic+Growth+Initiatives/26626830.html Wed, 10 Jun 2026 07:55:00 -0400 2F5 2F5.MU A.50113769 O.00624550 O.05713057 SCNI